Effect of delayed cord clamping on length of stay among patients with heart failure
Published
June 23, 2026
Paper ID
PAP-000013
Status
Published
DOI
10.65712/tmj.test000271
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on delayed cord clamping. Methods: We conducted a systematic review and meta-analysis across 14 centres between 2016 and 2022. Results: Serious adverse events were rare and similar between groups. length of stay occurred in 6% of the intervention group versus 12% of controls. Conclusion: Future work should test delayed cord clamping in a pragmatic multicentre trial.
Introduction
Guidelines make only a weak recommendation on delayed cord clamping. Earlier studies of delayed cord clamping were small or single-centre. Practice around delayed cord clamping varies widely between centres.
Earlier studies of delayed cord clamping were small or single-centre. The cost of length of stay to health systems is substantial. Guidelines make only a weak recommendation on delayed cord clamping.
Materials and Methods
We conducted a systematic review and meta-analysis across 12 centres between 2017 and 2025. Missing data were handled with multiple imputation. Eligible participants were patients with heart failure. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was length of stay, assessed blind to allocation. Eligible participants were patients with heart failure. Analyses were adjusted for age, sex and baseline severity.
Results
Serious adverse events were rare and similar between groups. length of stay occurred in 7% of the intervention group versus 33% of controls.
| Group | n | Events |
|---|---|---|
| Age < 65 | 210 | 83 |
| Age < 65 | 514 | 115 |
| Age ≥ 65 | 414 | 62 |
| Intervention | 892 | 77 |
Values are n (%) unless stated otherwise.

Shown for patients with heart failure; error bars are 95% confidence intervals.

Shown for patients with heart failure; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. 2474 participants were included (median age 72 years). 1645 participants were included (median age 70 years).
Discussion
Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better length of stay in patients with heart failure. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. Future work should test delayed cord clamping in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Conclusions
Delayed cord clamping may be offered for patients with heart failure to improve length of stay.
References
1. Herrera U, Okafor P, et al. Delayed cord clamping and ventilator-free days. Eur Heart J. 2011;70(7):510-1262.
2. Nasser H, Silva T, et al. Telemedicine follow-up and 30-day readmission. N Engl J Med. 2009;15(1):550-1709.
3. Nasser M, Mensah P, et al. Home-based cardiac rehabilitation and health-related quality of life. JAMA. 2021;46(1):352-994.
4. Nakamura W, Herrera J, et al. A sepsis alert system and chronic pain scores. BMJ. 2024;340(11):441-1287.
5. Nakamura K, Silva C, et al. Continuous glucose monitoring and chronic pain scores. JAMA. 2009;311(4):496-1303.
6. Nakamura T, Haddad A, et al. Delayed cord clamping and medication adherence. Crit Care Med. 2010;256(3):680-1426.
7. Ahmed Y, Kowalski D, et al. SGLT2 inhibitors and glycaemic control. Ann Intern Med. 2016;176(12):361-1398.
8. Larsen R, Costa F, et al. SGLT2 inhibitors and surgical site infection. JAMA. 2009;313(1):451-1182.
9. Haddad E, Moreau G, et al. Home-based cardiac rehabilitation and glycaemic control. Pediatrics. 2021;165(8):821-1680.
Appendices
Ethics approval: IRB-1130.